
Results
2
Stocks where the price continues to rise after more than a year of consistent gains.
2 companies
ABIVAX Société Anonyme
Market Cap: €9.2b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€117.50
7D
45.6%
1Y
1,612.8%
Valerio Therapeutics Société anonyme
Market Cap: €107.1m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.26
7D
30.3%
1Y
293.2%